Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Changes and Choices for Clinicians

Staff  |  Issue: June 2007  |  June 1, 2007

Clinician members will have more than enough sessions to keep them busy at the ACR Annual Scientific Meeting in Boston this November. The Annual Meeting Planning Committee (AMPC) continues to use attendee feedback and member input to create a meeting that offers vital content to every attendee.

“The goal of all the program changes is to create a meeting that has something in virtually every timeslot for all constituents of the ACR. For example, we tried to provide more choices for folks who have special interests, such as pure clinical medicine or basic science,” reflects Brian Mandell, MD, PhD, chair of the AMPC. “We realize that this will create dilemmas of too many choices for some people, but our philosophy is to offer more choices rather than fewer.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

New Sessions, New Schedules, More Choices

For the first time, the ACR will recorded some clinical sessions that run in opposition to similar topics and replay them the following day in the Encore Theater. A listing of these sessions will be available at the meeting.

Also, topics relevant to clinicians, which in the past might have been offered as part of the Frontiers in Translational Research preconference, will now be incorporated into other sessions at the meeting.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Another first this year is that additional programming will be offered at the same time as two of the morning plenary sessions. This decision, though controversial, was made in response to attendee feedback. “The plenary sessions are typically strong basic science,” explains Dr. Mandell. “That’s an important part of the meeting, but some of the clinicians felt that wasn’t the best use of their time and asked for relevant clinical sessions. The alternatives we provided are meant to do that.”

“Curbside Consults – Ask the Professors” is one alternative session. This session is the equivalent of an elevator consultation with speakers who have a particular area of expertise. “We’re posing a question in advance that they might otherwise get in a typical quick consult, and in the session we’ll offer a short clinical case scenario and ask the expert speakers how they’d respond to the clinical problem,” says Dr. Mandell. Another innovation will allow attendees to participate in the session. “We are planning on introducing use of an interactive audience response system into some sessions at the meeting,” he says.

Other new sessions include “Rheumatology Roundup,” which will offer highlights from the 2007 ACR Annual Scientific Meeting rather than from the year at large. At the session, leaders in the field will comment on abstracts presented during the annual meeting.

Page: 1 2 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingFrom the CollegeProfessional Topics Tagged with:ACR Annual Scientific MeetingCareer developmentEducationrheumatologistTraining

Related Articles

    ACR Convergence: Stronger Than Ever After More Than 8 Decades

    July 13, 2022

    Like solving sudoku, planning the ACR annual meeting requires an ability to recognize patterns and employ focused logical thinking, all the while remaining undaunted by the various paths possible to complete a grid from what looks like, at initial glance, an incomprehensible labyrinth of options. The patterns in this situation are not numbers, but sessions,…

    Enhanced Opportunities at the 2007 Meeting

    October 1, 2007

    The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.

    How to Provide Better Feedback to Fellows

    July 15, 2021

    Although providing feedback is often discussed as separate from teaching, it is the most important teaching we do as clinician-educators. Whether attending on the inpatient consult service or precepting in the clinic, providing direct feedback is the most effective way to help fellows advance their skills. Feedback, however, is only as good as the giver…

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences